Scarica l'app Stockscreener
0.285
16.09%
0.0395
Dopo l'orario di chiusura:
.27
-0.015
-5.26%
Precedente Chiudi:
$0.2455
Aprire:
$0.2429
Volume 24 ore:
43.89M
Relative Volume:
46.01
Capitalizzazione di mercato:
$2.53M
Reddito:
$149.50K
Utile/perdita netta:
$-6.96M
Rapporto P/E:
-0.2096
EPS:
-1.36
Flusso di cassa netto:
$-6.37M
1 W Prestazione:
-72.60%
1M Prestazione:
-75.85%
6M Prestazione:
-81.00%
1 anno Prestazione:
-88.41%
Intervallo 1D:
$0.2398
$0.2873
Intervallo di 1 settimana:
$0.2194
$1.07
Portata 52W:
$0.2194
$2.50
Biorestorative Therapies Inc Stock (BRTX) Company Profile
Nome
Biorestorative Therapies Inc
Settore
Industria
Telefono
(631) 760-8100
Indirizzo
40 MARCUS DRIVE, MELVILLE
Compare BRTX vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BRTX
Biorestorative Therapies Inc
|
0.285 | 2.18M | 149.50K | -6.96M | -6.37M | -1.36 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Biorestorative Therapies Inc Borsa (BRTX) Ultime notizie
BioRestorative Therapies closes $5 million public offering By Investing.com - Investing.com Nigeria
Biorestorative Therapies (NASDAQ:BRTX) Trading 5.9% Higher – Still a Buy? - Defense World
BioRestorative Closes $5 Million Public Offering of 14.3 Million Shares - Intellectia AI
BioRestorative Therapies closes $5 million public offering - Investing.com
BioRestorative Therapies, Inc. Completes Public Offering Raising Approximately $5.0 Million for Clinical and Research Initiatives - Quiver Quantitative
BioRestorative Announces Closing of $5.0 Million Public Offering - Bitget
Stem cell firm BioRestorative raises $5M for trials and R&D - Stock Titan
BioRestorative Announces Closing of $5.0 Million Public Offering - GlobeNewswire Inc.
BioRestorative prices $5M stock offering - MSN
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Form 424B4 BioRestorative Therapies - StreetInsider
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
BioRestorative Therapies stock plunges after $5 million public offering By Investing.com - Investing.com Australia
BioRestorative Therapies stock plunges after $5 million public offering - Investing.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
BioRestorative Therapies (OTCMKTS:BRTXQ) Shares Down 38.9%Here's Why - MarketBeat
BioRestorative Announces Pricing of $5.0 Million Public Offering - The Manila Times
Stem cell developer BioRestorative seeks $5M for BRTX-100 trials - Stock Titan
BioRestorative announces pricing of $5.0 million public offering - marketscreener.com
Is BioRestorative Therapies Inc.’s growth already priced inWeekly Trade Report & Daily Risk Controlled Trade Plans - mfd.ru
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
BioRestorative Therapies, Inc. Announces Positive Outcome from Type B Meeting with FDA - marketscreener.com
BioRestorative Announces Positive Outcome From Type B Meeting With FDA - Nasdaq
Biorestorative announces positive outcome from type B meeting with FDA - marketscreener.com
BioRestorative Therapies recently updated the timeline for its core research and development pipeline - Bitget
BioRestorative Therapies Receives Positive FDA Feedback on BRTX-100 Program for Accelerated BLA Approval Pathway - Quiver Quantitative
FDA meeting outlines expedited approval path for BioRestorative BRTX-100 - Stock Titan
BioRestorative concludes Phase II BRTX-100 trial enrolment for cLDD - Yahoo Finance
Biorestorative completes patient enrollment in landmark phase 2 trial of BRTX-100 for chronic lumbar disc disease - marketscreener.com
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
BioRestorative signs up 99 in chronic lumbar disc disease cell therapy trial - Stock Titan
BioRestorative Completes Patient Enrollment in Landmark Phase 2 Trial of BRTX-100 for Chronic Lumbar Disc Disease - Sahm
Street Watch: Can BioRestorative Therapies Inc weather a recessionWeekly Profit Recap & Fast Gain Stock Tips - baoquankhu1.vn
What’s the beta of BioRestorative Therapies Inc. stockMarket Activity Recap & Community Driven Trade Alerts - mfd.ru
Growth Review: Can BioRestorative Therapies Inc weather a recessionJuly 2025 Intraday Action & Community Shared Stock Ideas - baoquankhu1.vn
Guidance Update: Is BioRestorative Therapies Inc stock a hidden gemWeekly Investment Recap & Reliable Intraday Trade Alerts - baoquankhu1.vn
Financial Survey: Biorestorative Therapies (NASDAQ:BRTX) vs. Tenax Therapeutics (NASDAQ:TENX) - Defense World
BioRestorative Therapies (OTCMKTS:BRTXQ) Shares Down 2.6%Here's Why - MarketBeat
Is BioRestorative Therapies Inc stock overvalued or fairly pricedBear Alert & Proven Capital Preservation Methods - baoquankhu1.vn
Smart Money: Is BioRestorative Therapies Inc being accumulated by smart moneyQuarterly Profit Report & Long-Term Growth Portfolio Plans - baoquankhu1.vn
How rising interest rates impact BioRestorative Therapies Inc. stockTrade Exit Summary & Low Volatility Stock Suggestions - Улправда
Will BioRestorative Therapies Inc. (9OF) stock beat growth indexesIPO Watch & Daily Profit Maximizing Trade Tips - ulpravda.ru
How supply shortages influence BioRestorative Therapies Inc. (9OF) stockJuly 2025 Selloffs & Free Safe Entry Trade Signal Reports - Улправда
Biorestorative Therapies (NASDAQ:BRTX) Trading Up 5.9% – Here’s Why - Defense World
BioRestorative Therapies (OTCMKTS:BRTXQ) Stock Price Down 1.8%Should You Sell? - MarketBeat
Is BioRestorative Therapies Inc. stock in correction or buying zone2025 Key Highlights & Daily Market Momentum Tracking - Улправда
What technical charts say about BioRestorative Therapies Inc. stockEarnings Growth Summary & Weekly Stock Performance Updates - Улправда
Is BioRestorative Therapies Inc. stock vulnerable to regulatory risksJuly 2025 Weekly Recap & Target Return Focused Picks - Улправда
How BioRestorative Therapies Inc. stock benefits from tech adoptionJuly 2025 Breakouts & Accurate Buy Signal Alerts - DonanımHaber
Why BioRestorative Therapies Inc. stock could rally in 20252025 Price Targets & Scalable Portfolio Growth Methods - Bölüm Sonu Canavarı
Is BioRestorative Therapies Inc. stock positioned for long term growth2025 Bull vs Bear & Verified Momentum Stock Ideas - DonanımHaber
Biorestorative Therapies Inc Azioni (BRTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.12%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):